Twist Bioscience (TWST)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Synthetic Biologysrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Dilution Risk
MEDIUM DILUTION RISKDilution score: 36/100 (MEDIUM), 16.2 months cash
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 19.08% of float, squeeze risk: MODERATE
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Is Twist Bioscience (TWST) Quietly Becoming Core Infrastructure for AI-Driven Biofoundry Platforms?
- Biofoundry-as-a-Service Global Market Report 2026 | Capitalize on 21.6% CAGR with GenScript, Ginkgo Bioworks, Twist Bioscience and Codexis Driving AI Automation
- Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera
- Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
- Cathie Wood’s ARKG Is Crushing Her Other ETFs: 2 Biotech Bets Have Surged Nearly 6X This Year
- Twist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI Upside
- Twist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year Run
- What Needs To Be True To Buy Twist Bioscience Stock Now?
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- External Validation of the Time to Walking Independently After Stroke (TWIST) Prediction Algorithm within 72 Hours Poststroke. — Neurorehabil Neural Repair 2026 Aug 26 PMID 42648903
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Twist Bioscience.
Full TWST Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.